Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Indivior Pharmaceuticals is a global leader in addiction medicine. Headquartered in the US, the company focuses on developing innovative therapies for opioid use disorder and mental health conditions to help patients worldwide lead better lives through dedicated medical research and treatment solutions.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Indivior Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Indivior Pharmaceuticals last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 1.15 USD.
Across its last 3 earnings reports, Indivior Pharmaceuticals stock moved by ±4.8% on average the following day. The largest reaction was +7.7% on 04/30/2026; 2 of 3 reactions were positive.
Indivior Pharmaceuticals has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.